Explain this page
Arphra AIPlain-English read on Halozyme Therapeutics, Inc.’s valuationInsider signal · 90d
Net sellers
Bought
$0
Sold
$3.4M
Txns
9
Over the trailing 90 days insiders are net sellers — $0 bought against $3.4M sold across 9 open-market Form-4 transactions. Much insider selling is scheduled (10b5-1); read the asymmetry, not any single print.
Open-market Form 4
· insider_tradesInsider transactions · last 365d
Net −$3.4M0 buys
| Insider | Role | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | −1,500 | $101.5K | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | −400 | $26.5K | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | −2,000 | $137.5K | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | −6,100 | $425.1K | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | −16,600 | $1.1M | Jun 02, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | −3,400 | $226.9K | Jun 02, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | −1,610 | $106.9K | Jun 01, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | −12,989 | $875.6K | Jun 01, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | −5,401 | $369.1K | Jun 01, 2026 |
Transaction mix · 365d
100%
Sells9 · $3.4M
Buys0 · $0
Top sellers · 365d
Torley Helen · director, officer: PRESIDENT AND CEO−$3.4M
Transactions
9
0 buys · 9 sells
Bought
$0
Open market
Sold
$3.37M
Open market
Net flow
−$3.37M
Buys − sells
Transactions
| Insider | Role | Action | Shares | Price | Value | Trade date | Filing |
|---|---|---|---|---|---|---|---|
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 1,500 | $67.68 | $101.51K | Jun 03, 2026 | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 400 | $66.37 | $26.55K | Jun 03, 2026 | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 2,000 | $68.74 | $137.47K | Jun 03, 2026 | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 6,100 | $69.69 | $425.12K | Jun 03, 2026 | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 16,600 | $66.31 | $1.1M | Jun 02, 2026 | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 3,400 | $66.75 | $226.93K | Jun 02, 2026 | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 1,610 | $66.39 | $106.88K | Jun 01, 2026 | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 12,989 | $67.41 | $875.59K | Jun 01, 2026 | Jun 03, 2026 |
| Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 5,401 | $68.35 | $369.14K | Jun 01, 2026 | Jun 03, 2026 |
By insider
- Torley Helen−$3.37Mdirector, officer: PRESIDENT AND CEO0B · 9S
Top 10 holders · 8 quarters
13F position evolutionNo 13F history in
institutional_holders for HALO-US.